Get Access
TreelipBiomarker Patient-Selection Radar
Solid Tumor OncologyMethodology
Cdx Established Context

ALK fusion

NSCLC · Immune Checkpoint Inhibitor

ALK fusion is flagged as cdx established context because public trials show inclusion required evidence in 36 contexts. FDA CDx context exists.

Back to report
Role evidence

Usage summary

Strongest role: Inclusion Required

Inclusion-required count: 35

Treatment-assignment count: 0

Stratification count: 0

Threshold snippets

Fragmentation view

Threshold count: 19

Common snippets: PD-L1 TPS ≥50% | MSI-H | PD-L1 TPS >50%

Threshold label: Moderate

FDA CDx context

Mapping summary

CDx label: Fda Cdx Context Exists

CDx maturity score: 5/5

Confidence: Medium

Patent-density signal

Diagnostic appendix

Signal count: 0

Recent signals: 0

Density label: Low

Source links

Evidence paths

https://clinicaltrials.gov/study/NCT06364917 | https://clinicaltrials.gov/study/NCT04013542 | https://clinicaltrials.gov/study/NCT03225664 | https://clinicaltrials.gov/study/NCT03516981 | https://clinicaltrials.gov/study/NCT07360743 | https://clinicaltrials.gov/study/NCT02194738 | https://clinicaltrials.gov/study/NCT07111520 | https://clinicaltrials.gov/study/NCT03564197 | https://clinicaltrials.gov/study/NCT07285434 | https://clinicaltrials.gov/study/NCT03447678 | https://clinicaltrials.gov/study/NCT06119581 | https://clinicaltrials.gov/study/NCT03948763 | https://clinicaltrials.gov/study/NCT06890598 | https://clinicaltrials.gov/study/NCT06447662 | https://clinicaltrials.gov/study/NCT04967417 | https://clinicaltrials.gov/study/NCT06711900 | https://clinicaltrials.gov/study/NCT06687369 | https://clinicaltrials.gov/study/NCT04619797 | https://clinicaltrials.gov/study/NCT04274907 | https://clinicaltrials.gov/study/NCT03215706 | https://clinicaltrials.gov/study/NCT02382406 | https://clinicaltrials.gov/study/NCT02434081 | https://clinicaltrials.gov/study/NCT04623775 | https://clinicaltrials.gov/study/NCT03664024 | https://clinicaltrials.gov/study/NCT03304093 | https://clinicaltrials.gov/study/NCT02955290 | https://clinicaltrials.gov/study/NCT03275597 | https://clinicaltrials.gov/study/NCT04521075 | https://clinicaltrials.gov/study/NCT03836352 | https://clinicaltrials.gov/study/NCT06362369 | https://clinicaltrials.gov/study/NCT05714553 | https://clinicaltrials.gov/study/NCT05061017 | https://clinicaltrials.gov/study/NCT03083691 | https://clinicaltrials.gov/study/NCT04267848 | https://clinicaltrials.gov/study/NCT03468985 | https://clinicaltrials.gov/study/NCT06908993